Chemist+Druggist’s Post

NICE - National Institute for Health and Care Excellence has shared the outcome of its recent consultation, opting to move forward with the 'incorporation' proposal while setting aside the more ambitious 'integration' plan. Sandoz responded positively to the consultation and supports this outcome, highlighting the chance to enhance patient access to off-patent medicines. NHS stakeholders have also very clearly underlined the importance of considering biosimilars and generics, as per responses. The focus on leveraging new evidence to potentially broaden patient populations is a key aspect of NICE's decision. Considering the significant 72% price reduction post biosimilar entry could further expand patient access, where NICE funding restrictions existed previously. The incorporation process holds promise for the NHS to drive efficiencies, treat more patients, and improve population health using off-patent medicines. For further details, refer to the NICE board papers here: https://lnkd.in/eBdKREW7 #NICE #ExpandingAccess #OffPatentMedicines

HFMA members: We need your expertise Some of the questions in our groups have not received a response yet. We're turning to you, our industry experts, to help answer them. Please see the list of discussions below, join the group and add your knowledge/best practices to assist your fellow members. Thank you! Does anyone know what the service address would be for a facility-owned mobile unit on claims? https://ow.ly/I6I250RGlgI Would anyone have a self-pay policy for a rural healthcare facility? https://ow.ly/1f0g50RGlgE Would other healthcare institutions be interested in connecting on billing solutions for providers in multiple states? https://ow.ly/YiuN50RGlgJ How should we bill for services provided by physicians coming to us under a fellowship? https://ow.ly/Je1m50RGlgF

We’re getting excited about the Healthcare Financial Management Association (HFMA) Region 1 Conference in Montville, CT, on May 30-31! We look forward to the discussions about the future of healthcare and gaining valuable insights into revenue cycle management, reimbursement dynamics, strategic planning, and more! George Krueger and Les Rescorl will discuss how we help organizations like yours use the right operational intelligence to make a MAJOR impact on your revenue and expenses. Check out how we’ve helped Stillwater Medical reduce annual labor expenses in the mid-six figures while increasing productivity 👇 #HFMA #healthcarefinance #healthcareanalytics

Dear Physician, 🖋️ As you navigate the complexities of medicine, remember each patient's journey is a testament to your dedication and expertise. Your passion for healing and commitment to excellence inspire us all. Keep pushing boundaries, embracing challenges, and nurturing your remarkable journey. Here's to the impact you continue to make in the lives entrusted to your care. With admiration and support, The Association of Physicians of Great Britain and Ireland (AoPGBI) #HealthcareHeroes #InterdisciplinaryResearch #HealthcareInnovation #MedicalInnovation #TranslationalMedicine #AoPGBI

**IMPORTANT UPDATE about CBRCanada’s CoP Registrations** Please read poster first. Google form link: https://lnkd.in/gX6QP5Ri CBRCanada's Community of Practice actively brings together CBRCanada members to learn from each other, network, and exchange best and promising practices for community-based research. Each Community of Practice session is led by a guest speaker(s) from our network to introduce a big challenge/opportunity in community-based research, followed by a facilitated discussion among members. To view upcoming Community of Practice events / topics, view the CBRCanada events page at https://lnkd.in/d5YjpVVf The group meets the second Friday of every other month. Meetings are one hour, informal, and participatory. We will email you each month with information about the Community of Practice topic and guest speaker and you are welcome to come to as many as you wish. By signing up for the Community of Practice, you will receive re-occurring calendar invitations for the entire year. If you would like to be removed from this group, you can unsubscribe at anytime by emailing info@communityresearchcanada.ca The Community Of Practice is open for CBRCanada members only. If you are employed, studying, or affiliated with any CBRCanada member institution/organization, you are already considered a member. If you are unsure if your institution is covered check out https://lnkd.in/grTCQ4gG

The deadline for EU-CTR slim transitions is less than a month away! After October 16th, submissions may be treated as full transitions, subject to Member States’ discretion. We strongly recommend that sponsors take advantage of the slim transition opportunity, which requires fewer documents than the full transition and may offer shorter timelines. Existing studies must be transitioned to the CTIS platform, even if there is uncertainty whether a study will still have active sites or patients in EEA countries after January 31st, 2025. However, if the end of the study is anticipated early next year, then sponsors could avoid substantial modification for alignment with EU-CTR requirements. With new transparency rules introduced on June 18th, there is a significant reduction in the number of documents made publicly available. Our blog shares advice for ensuring compliance with EU-CTR to maintain the validity of your clinical trials in the EEA. We are always available for a conversation to discuss consultancy approaches to support sponsors to meet the requirements for the transition deadline.

With turnover rates between 8% and 10%, along with medium (or higher) burnout rates at 37% for providers (based on AMGA's ProSat insights), do you believe that your providers feel engaged? Let AMGA be your third-party unbiased partner to gauge provider satisfaction - a partner that understands the needs and challenges of the provider workforce!

The deadline for EU-CTR slim transitions is less than a month away! After October 16th, submissions may be treated as full transitions, subject to Member States’ discretion. We strongly recommend that sponsors take advantage of the slim transition opportunity, which requires fewer documents than the full transition and may offer shorter timelines. Existing studies must be transitioned to the CTIS platform, even if there is uncertainty whether a study will still have active sites or patients in EEA countries after January 31st, 2025. However, if the end of the study is anticipated early next year, then sponsors could avoid substantial modification for alignment with EU-CTR requirements. With new transparency rules introduced on June 18th, there is a significant reduction in the number of documents made publicly available. Our blog shares advice for ensuring compliance with EU-CTR to maintain the validity of your clinical trials in the EEA. We are always available for a conversation to discuss consultancy approaches to support sponsors to meet the requirements for the transition deadline. #euctr #clinicaltrials #withheart Esther Gil Celina González-Colaço

⏰ Time is running out for EU Clinical Trial Regulation 536/2014 (EU-CTR) compliance! Sponsors now have less than nine months to transition or face termination in all 30 EEA countries ❌ Thousands of clinical trials have yet to start the process, which can take 60 days or more for a slim dossier submission, timelines we could see stretching even longer as demand ramps up. In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Esther Gil, Celina González-Colaço, and Claire Browne share guidance for navigating this complex and consequential process, including actionable recommendations for timely compliance. Learn more in the article below and subscribe for the latest #NovelInsights from our bi-weekly clinical trial newsletter!

Question: I have a challenge. The lab i work for does not have a website and HCPC insisted i must provide official work email not Gmail, yahoo. Is there anyway to go round this? Me: It is hard to get registered when you work for a lab or diagnostic centre without a website and an official email address. You can check out a big lab in your location with the website and official email address. You can work for them as a volunteer and get references from them for your International or HCPC registration.